Large-scale testing (Phase 3)Ended earlyNCT00120328
What this trial is testing
To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy
Who this might be right for
Diabetic Nephropathy
Speedel Pharma Ltd. 2,364